Skip to main content
Top
Published in: Journal of General Internal Medicine 11/2008

01-11-2008 | Case Reports/Clinical Vignettes

Pelvic Pain as an Unusual First Presentation of a Demyelinating Disease

Authors: A. Lukas Loschner, MD, John E. Snyder, MS, MD

Published in: Journal of General Internal Medicine | Issue 11/2008

Login to get access

Abstract

Pelvic pain as the presenting symptom of demyelinating disease is rare. We report on a 49-year-old female patient that initially had symptoms of pain and anesthesia in the perineum. Symptoms later evolved to include both lower and upper extremity weakness and were associated with enhancing spinal cord lesions on MRI. Recognizing that the patient’s disease was localized only to the spinal cord led to an eventual serological diagnosis of neuromyelitis optica (Devic’s disease), a demyelinating syndrome that is now considered distinct from multiple sclerosis and that primarily affects the spinal cord and optic nerves. Pelvic pain is an unusual first presentation of this illness. Additionally, this case illustrates the challenges of establishing a diagnosis of neuromyelitis optica. Recognizing the distinct clinical features of this rare illness, referring specifically from a spinal cord or ophthalmogical etiology, is essential for its rapid diagnosis, and hence for initiation of appropriate therapy.
Literature
1.
go back to reference Jamieson DJ, Steege JF. The prevalence of dysmenorrhea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary care practices. Obstet Gynecol. 1996;87(1):55–8. Jan.PubMedCrossRef Jamieson DJ, Steege JF. The prevalence of dysmenorrhea, dyspareunia, pelvic pain, and irritable bowel syndrome in primary care practices. Obstet Gynecol. 1996;87(1):55–8. Jan.PubMedCrossRef
2.
go back to reference Kassirer M. Multiple sclerosis and pain: a medical focus. Int J MS Care. 2000;2(3):40–7. [Serial online]. Oct. Kassirer M. Multiple sclerosis and pain: a medical focus. Int J MS Care. 2000;2(3):40–7. [Serial online]. Oct.
3.
go back to reference Solaro C, Uccelli MM, Mancardi GL. A patient with multiple sclerosis and Down’s syndrome with a rare paroxysmal symptom at onset. Eur J Neurol. 1999;6(4):505–7. Jul.PubMedCrossRef Solaro C, Uccelli MM, Mancardi GL. A patient with multiple sclerosis and Down’s syndrome with a rare paroxysmal symptom at onset. Eur J Neurol. 1999;6(4):505–7. Jul.PubMedCrossRef
4.
go back to reference Wingerchuk DM. Diagnosis and Treatment of Neuromyelitis Optica. Neurologist. 2007;13(1):2–11. January.PubMedCrossRef Wingerchuk DM. Diagnosis and Treatment of Neuromyelitis Optica. Neurologist. 2007;13(1):2–11. January.PubMedCrossRef
5.
go back to reference Misu T, Fujihara K, Kakita A, et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain. 2007;130(5):1224–34. May.PubMedCrossRef Misu T, Fujihara K, Kakita A, et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain. 2007;130(5):1224–34. May.PubMedCrossRef
6.
go back to reference Roemer SF, Parisi JE, Lennon VA, et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain. 2007;130(5):1194–205. May.PubMedCrossRef Roemer SF, Parisi JE, Lennon VA, et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain. 2007;130(5):1194–205. May.PubMedCrossRef
7.
go back to reference Jarius S, Franciotta D, Bergamaschi R, et al. NMO-IgG in the diagnosis of neuromyelitis optica. Neurology. 2007;68(13):1076–77. 27 March.PubMedCrossRef Jarius S, Franciotta D, Bergamaschi R, et al. NMO-IgG in the diagnosis of neuromyelitis optica. Neurology. 2007;68(13):1076–77. 27 March.PubMedCrossRef
8.
9.
go back to reference Matiello MA, Jacob AA, Wingerchuk DM, Weinshenker BG. Neuromyelitis optica. Curr Opin Neurol. 2007;20(3):255–60. June.PubMedCrossRef Matiello MA, Jacob AA, Wingerchuk DM, Weinshenker BG. Neuromyelitis optica. Curr Opin Neurol. 2007;20(3):255–60. June.PubMedCrossRef
10.
go back to reference Weinshenker BG, O’Brien PC, Petterson TM, et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol. 1999;46:878–86.PubMedCrossRef Weinshenker BG, O’Brien PC, Petterson TM, et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol. 1999;46:878–86.PubMedCrossRef
11.
go back to reference Weinstock-Guttman B, Ramanathan M, Lincoff N, et al. Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic Disease). Arch Neurol. 2006;63:957–63.PubMedCrossRef Weinstock-Guttman B, Ramanathan M, Lincoff N, et al. Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic Disease). Arch Neurol. 2006;63:957–63.PubMedCrossRef
12.
go back to reference Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C. An open label study of the effects of rituximab in Neuromyelitis optica. Neurology. 2005;64:1270–72.PubMed Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C. An open label study of the effects of rituximab in Neuromyelitis optica. Neurology. 2005;64:1270–72.PubMed
13.
go back to reference Wingerchuk DM, Hogancamp WF, O’Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology. 1999;53(5):1107–14. 22 September.PubMed Wingerchuk DM, Hogancamp WF, O’Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic’s syndrome). Neurology. 1999;53(5):1107–14. 22 September.PubMed
14.
go back to reference Hemmer B, Stüve O. Revised criteria for neuromyelitis optica-a new diagnostic standard? Nat Clin Pract Neurol. 2007;3:132–3.PubMedCrossRef Hemmer B, Stüve O. Revised criteria for neuromyelitis optica-a new diagnostic standard? Nat Clin Pract Neurol. 2007;3:132–3.PubMedCrossRef
15.
go back to reference Jantos M. Understanding Chronic Pelvic Pain. Pelviperineology. 2007;26:66–9. Jantos M. Understanding Chronic Pelvic Pain. Pelviperineology. 2007;26:66–9.
16.
go back to reference Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66:1485–9.PubMedCrossRef Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66:1485–9.PubMedCrossRef
17.
go back to reference Weinshenker BG. Neuromyelitis Optica Is Distinct From Multiple Sclerosis. Arch Neurol. 2007;64:899–901.PubMedCrossRef Weinshenker BG. Neuromyelitis Optica Is Distinct From Multiple Sclerosis. Arch Neurol. 2007;64:899–901.PubMedCrossRef
Metadata
Title
Pelvic Pain as an Unusual First Presentation of a Demyelinating Disease
Authors
A. Lukas Loschner, MD
John E. Snyder, MS, MD
Publication date
01-11-2008
Publisher
Springer-Verlag
Published in
Journal of General Internal Medicine / Issue 11/2008
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-008-0767-x

Other articles of this Issue 11/2008

Journal of General Internal Medicine 11/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.